Alexander disease: models, mechanisms, and medicine

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Alexander disease is a primary astrocyte disorder.
• It is caused by gain-of-function mutations in the glial fibrillary acidic protein (GFAP) gene.
• These mutations lead to protein aggregation and reactive astrocyte responses, severely impacting the central nervous system.

Purpose of the Study:

• To elucidate the underlying mechanisms of Alexander disease.
• To address enigmatic aspects such as GFAP accumulation initiation, astrocyte pathology, and the link between astrocyte dysfunction and myelin deficits.
• To identify novel therapeutic strategies for Alexander disease.

Main Methods:

• Utilized established and novel cellular and animal models.
• Investigated GFAP aggregation and astrocyte reactivity.
• Examined the relationship between astrocyte dysfunction and myelin deficits.

Main Results:

• Significant progress has been made in understanding Alexander disease pathogenesis over the past two decades.
• Recent studies using advanced models have begun to clarify initiating events and disease variability.
• New therapeutic targets are emerging from ongoing research.

Conclusions:

• Despite advances, key questions regarding Alexander disease initiation and progression remain.
• Current research using diverse models is crucial for understanding the complex interplay of factors.
• Therapeutic development holds promise for future effective treatments for Alexander disease.